首页> 外文期刊>Терапевтичесκий архив >Damage of vascular endothelium in the treatment of acute leukemia: in vitro study
【24h】

Damage of vascular endothelium in the treatment of acute leukemia: in vitro study

机译:急性白血病治疗中血管内皮损伤:体外研究

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: Cytostatic drugs used in the treatment of hemopoietic malignancies affect cells of other organs and systems, vascular endothelium, in particular. This leads to cardiovascular complications. We studied effects of some drugs and their combinations on cultured human endothelial cells (EC). MATERIAL AND METHODS: Primary culture of umbilical human vein EC was used in the study. Cytosinearabinoside (cytozar, alexan, cytarabin) and daunorubicin were added in concentration from 1 ng/ml to 1 mg/ml; the action of the drugs was assessed by morphology of the cells, their viability, inclusion of bromodesoxyuridine by means of cloning, immunohistochemistry and flow cytofluorimetry. RESULTS: It is shown that in a wide range of concentrations cytosinearabinoside and daunorubicine cause specific structural-functional changes in the cells related to cytostatic and cytotoxic effects. CONCLUSION: The data of the study confirm that cardiovascular complications in the course of acute leukemia treatment are resultant from systemic damage to vascular endothelium.
机译:目的:用于治疗造血恶性肿瘤的细胞抑制药物影响其他器官和系统,血管内皮的细胞。这导致心血管并发症。我们研究了一些药物的影响及其对培养人内皮细胞(EC)的组合。材料与方法:研究中使用脐部人静脉EC的原发性培养物。浓度从1ng / ml至1mg / ml加入细胞增生苷(细胞曲石,亚历扬,囊内糖)和Daunorubicin;通过细胞的形态,其活力,通过克隆,免疫组织化学和流动细胞杂氟荧光测量来评估药物的形态学评估。结果:表明,在各种浓度的浓度下,细胞苷和Daunorubicine导致细胞抑制和细胞毒性效应相关的细胞特异性结构功能变化。结论:研究数据证实,急性白血病治疗过程中的心血管并发症是从系统性损伤对血管内皮的损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号